Evidence map›Paper›PMID 17693463›Full record

ArticleBiophysical journal2007

Modeling hypertrophic IP3 transients in the cardiac myocyte.

Michael Cooling, Peter Hunter, Edmund J Crampin

Open access · bronzeAbstract read
In one paragraph

Article in Biophysical journal, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. CaBiophysical journal · 2020
    Article
  8. Article
  9. Article
  10. Review
  11. Quantitative systems models illuminate arrhythmia mechanisms in heart failure: Role of the NaWiley interdisciplinary reviews. Systems biology and medicine · 2019
    Review
  12. Modular modelling with Physiome standards.The Journal of physiology · 2016
    Article
  13. Mathematical modeling of cardiac growth and remodeling.Wiley interdisciplinary reviews. Systems biology and medicine · 2016
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Cardiac models in drug discovery and development: a review.Critical reviews in biomedical engineering · 2011
    Review
  19. CellML metadata standards, associated tools and repositories.Philosophical transactions. Series A, Mathematical, physical, and engineering sciences · 2009
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Michael CoolingAuckland Bioengineering Institute, Department of Engineering Science, University of Auckland, New Zealand. m.cooling@auckland.ac.nz
Peter Hunter
Edmund J Crampin
University of Auckland · NZAuckland University of Technology · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac hypertrophy is a known risk factor for heart disease, and at the cellular level is caused by a complex interaction of signal transduction pathways. The IP3-calcineurin pathway plays an important role in stimulating the transcription factor NFAT which binds to DNA cooperatively with other hypertrophic transcription factors. Using available kinetic data, we construct a mathematical model of the IP3 signal production system after stimulation by a hypertrophic alpha-adrenergic agonist (endothelin-1) in the mouse atrial cardiac myocyte. We use a global sensitivity analysis to identify key controlling parameters with respect to the resultant IP3 transient, including the phosphorylation of cell-membrane receptors, the ligand strength and binding kinetics to precoupled (with G(alpha)GDP) receptor, and the kinetics associated with precoupling the receptors. We show that the kinetics associated with the receptor system contribute to the behavior of the system to a great extent, with precoupled receptors driving the response to extracellular ligand. Finally, by reparameterizing for a second hypertrophic alpha-adrenergic agonist, angiotensin-II, we show that differences in key receptor kinetic and membrane density parameters are sufficient to explain different observed IP3 transients in essentially the same pathway.

Indexed as

Adrenergic alpha-AgonistsAngiotensin IIAnimalsCell MembraneEndothelin-1FerretsInositol 1,4,5-TrisphosphateModels, BiologicalModels, TheoreticalMyocytes, CardiacPhospholipase C betaPhosphorylationRatsReceptors, G-Protein-CoupledSignal TransductionAdrenergic alpha-AgonistsAngiotensin IIEndothelin-1Inositol 1,4,5-TrisphosphatePhospholipase C betaReceptors, G-Protein-Coupled

Identifiers

PMID17693463
PMCPMC2072074
OpenAlexW2028307228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.